- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02712294
Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension
Impact of Peripheral Neuromuscular Electrical Stimulation on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension
Pulmonary hypertension (PH) features symptoms related to a decreased cardiac autonomic response, pulmonary function and exercise capacity.
Non-pharmacological interventions are low cost and can significant enhance outcomes in these patients. Neuromuscular electrical stimulation (NMES) has been proposed as a viable therapeutic approach in patients with functional limitations, particularly those that present with difficulty to perform exercise protocols.
Objective: to evaluate the impact of NMES on exercise capacity, spirometry values and quality of life of patients with PH.
Material and methods: prospective randomized controlled study with a control group (GC, n9) and NMES goup (GE, n8). Quality of life and exercise capacity through the six-minute walk test (6MWT) were assessed before and after the NMES protocol.
Results: the GE presented with a significant improvement in distance walked in the 6MWT, cycle ergometry, spirometry and quality of life in the areas of vitality, emotional and social aspects of the questionnaire Short Form Health Survey-36.
Conclusion: NMES is a useful tool in the treatment of patients with PH, resulting in improved exercise capacity, quality of life and lung function testing.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Sao Paulo, Brasilien, 01221-020
- Santa Casa of Sao Paulo Medical School
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Males and females greater than or equal to 18 years of age, clinically stable with optimized drug therapy in the last 3 months, previously diagnosed with a mean pulmonary arterial pressure ≥ 25 mmHg by right heart catheterization and who agreed to participate by signing an informed consent were included.
Exclusion Criteria:
Exclusion criteria included a diagnosis of Down syndrome, orthopedic disease or neurologic or diagnoses, history of acute heart attack, use of beta-blockers, any urgent or elective surgical intervention during the implementation of the protocol, those who used assistive devices to ambulate or develop an infectious process during the study protocol.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Control Group (GC)
The GC received standard ambulatory care, including routine exams and drug therapy.
All patients were reassessed after the 2 month protocol.
|
|
|
Experimentell: NMES Group (GE)
Receiving the usual care and guidance on their illness, underwent 30 minute NMES sessions twice a week for two months using an electrostimulator.
Specifically, 5 cm adhesive surface electrodes in four alternate channels on the Rectus Femoris (two channels the right and two on the left) were used to deliver two-phase symmetrical currents, with a rectangular pulse wave at a frequency of 35 Hz and pulse duration of 250 μ.
The time of ascent and descent was one second, contraction time was four seconds and relaxation was eight seconds.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Distance in six-minute walk test
Tidsram: change from baseline in distance at 2 months
|
analysis of distance
|
change from baseline in distance at 2 months
|
|
Oxygen saturation in six-minute walk test
Tidsram: change from baseline in oxygen saturation at 2 months
|
analysis of oxygen saturation at end of test
|
change from baseline in oxygen saturation at 2 months
|
|
Systolic blood pressure in six-minute walk test
Tidsram: change from baseline in systolic blood pressure at 2 months
|
analysis of systolic blood pressure at end of test
|
change from baseline in systolic blood pressure at 2 months
|
|
Diastolic blood pressure in six-minute walk test
Tidsram: change from baseline in diastolic blood pressure at 2 months
|
analysis of diastolic blood pressure at end of test
|
change from baseline in diastolic blood pressure at 2 months
|
|
Heart rate in six-minute walk test
Tidsram: change from baseline in heart rate at 2 months
|
analysis of heart rate at end of test
|
change from baseline in heart rate at 2 months
|
|
Borg scale in six-minute walk test
Tidsram: change from baseline in Borg scale at 2 months
|
analysis of Borg scale at end of test
|
change from baseline in Borg scale at 2 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The Medical Outcomes Study 36-item Short Form Health Survey
Tidsram: change from baseline at 2 months
|
The questionnaire covers 36 items, designed to assess health concepts
|
change from baseline at 2 months
|
|
Forced vital capacity
Tidsram: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
|
Forced expiratory volume in the first second
Tidsram: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
|
Forced expiratory flow 25-75 %
Tidsram: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
|
Ratio of forced expiratory volume in the first second and forced vital capacity
Tidsram: change from baseline at 2 months
|
spirometric analysis
|
change from baseline at 2 months
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Parece 517.472
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .